Article R5124-65 of the French Public Health Code
Subject to the provisions of article L. 1453-7, and articles L. 4311-28, L. 4321-20 and L. 4343-1, advertising in favour of pharmaceutical companies and establishments may not include any offer of premiums, objects, products or material advantages, provided directly or indirectly, of any nature whatsoever, unless they are of negligible value.